TORONTO, CANADA, and OSAKA, JAPAN: - Six World Leading Drug Makers Contribute $50 Million for Early-Stage Research - New Approach Speeds Drug Development by Sharing Risks
...
TUSTIN, CA: Additional Preclinical Prostate Cancer Data Indicates Potent Immune Stimulation by PS-Targeting Antibodies Resulting in a 40% Cure Rate
...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.